Cargando…

Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial

BACKGROUND: Current guidelines for the diagnosis and management of patients with stable coronary artery disease (CAD) recommend functional stress testing for risk stratification prior to revascularization procedures. Cardiac magnetic resonance imaging (CMR) is a modality of choice for stress testing...

Descripción completa

Detalles Bibliográficos
Autores principales: Buckert, Dominik, Witzel, Simon, Cieslik, Maciej, Tibi, Raid, Rottbauer, Wolfgang, Bernhardt, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534045/
https://www.ncbi.nlm.nih.gov/pubmed/28754155
http://dx.doi.org/10.1186/s13063-017-2101-6
_version_ 1783253713600643072
author Buckert, Dominik
Witzel, Simon
Cieslik, Maciej
Tibi, Raid
Rottbauer, Wolfgang
Bernhardt, Peter
author_facet Buckert, Dominik
Witzel, Simon
Cieslik, Maciej
Tibi, Raid
Rottbauer, Wolfgang
Bernhardt, Peter
author_sort Buckert, Dominik
collection PubMed
description BACKGROUND: Current guidelines for the diagnosis and management of patients with stable coronary artery disease (CAD) recommend functional stress testing for risk stratification prior to revascularization procedures. Cardiac magnetic resonance imaging (CMR) is a modality of choice for stress testing because of its capability to detect myocardial ischemia sensitively and specifically. Nevertheless, evidence from randomized trials evaluating a CMR-based management of stable CAD patients in comparison to a more common angiography-based approach still is limited. METHODS/DESIGN: Patients presenting themselves with symptoms indicating a stable CAD and a class I or IIa indication for diagnostic coronary angiography are prospectively screened and enrolled in the study. All subjects receive a basic cardiological work-up and guideline-directed medical therapy. A 1:1 randomization in two groups is being performed. Patients in group 1 undergo diagnostic coronary angiography and subsequent revascularization according to current guidelines. Subjects in group 2 undergo adenosine stress CMR and in case of myocardial ischemia are sent to coronary angiography. Follow-up is planned for 3 years. During this time, the number of primary endpoints (defined as cardiac death and non-fatal myocardial infarction) and unplanned invasive procedures will be documented. Furthermore, symptom burden and quality of life will be assessed by use of the Seattle Angina Questionnaire. Sample size is calculated to prove non-inferiority of the CMR-based approach. DISCUSSION: In case this study is able to accomplish its aim to prove non-inferiority of the CMR-based management in patients with stable CAD; the importance of this emerging modality may further increase. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02580851. Registered on 14 October 2015. Unique Protocol ID: 237/11 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-017-2101-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5534045
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55340452017-08-03 Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial Buckert, Dominik Witzel, Simon Cieslik, Maciej Tibi, Raid Rottbauer, Wolfgang Bernhardt, Peter Trials Study Protocol BACKGROUND: Current guidelines for the diagnosis and management of patients with stable coronary artery disease (CAD) recommend functional stress testing for risk stratification prior to revascularization procedures. Cardiac magnetic resonance imaging (CMR) is a modality of choice for stress testing because of its capability to detect myocardial ischemia sensitively and specifically. Nevertheless, evidence from randomized trials evaluating a CMR-based management of stable CAD patients in comparison to a more common angiography-based approach still is limited. METHODS/DESIGN: Patients presenting themselves with symptoms indicating a stable CAD and a class I or IIa indication for diagnostic coronary angiography are prospectively screened and enrolled in the study. All subjects receive a basic cardiological work-up and guideline-directed medical therapy. A 1:1 randomization in two groups is being performed. Patients in group 1 undergo diagnostic coronary angiography and subsequent revascularization according to current guidelines. Subjects in group 2 undergo adenosine stress CMR and in case of myocardial ischemia are sent to coronary angiography. Follow-up is planned for 3 years. During this time, the number of primary endpoints (defined as cardiac death and non-fatal myocardial infarction) and unplanned invasive procedures will be documented. Furthermore, symptom burden and quality of life will be assessed by use of the Seattle Angina Questionnaire. Sample size is calculated to prove non-inferiority of the CMR-based approach. DISCUSSION: In case this study is able to accomplish its aim to prove non-inferiority of the CMR-based management in patients with stable CAD; the importance of this emerging modality may further increase. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02580851. Registered on 14 October 2015. Unique Protocol ID: 237/11 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-017-2101-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-28 /pmc/articles/PMC5534045/ /pubmed/28754155 http://dx.doi.org/10.1186/s13063-017-2101-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Buckert, Dominik
Witzel, Simon
Cieslik, Maciej
Tibi, Raid
Rottbauer, Wolfgang
Bernhardt, Peter
Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial
title Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial
title_full Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial
title_fullStr Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial
title_full_unstemmed Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial
title_short Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial
title_sort magnetic resonance adenosine perfusion imaging as gatekeeper of invasive coronary intervention (magnet): study protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534045/
https://www.ncbi.nlm.nih.gov/pubmed/28754155
http://dx.doi.org/10.1186/s13063-017-2101-6
work_keys_str_mv AT buckertdominik magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial
AT witzelsimon magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial
AT cieslikmaciej magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial
AT tibiraid magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial
AT rottbauerwolfgang magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial
AT bernhardtpeter magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial